Carisma Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CARM and other ETFs, options, and stocks.

About CARM

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors.

CEO

Steven Kelly

CEOSteven Kelly

Employees

Employees46

Headquarters

Philadelphia, Pennsylvania

HeadquartersPhiladelphia, Pennsylvania

Founded

2016

Founded2016

Employees

Employees46

CARM Key Statistics

Market cap

9.44M

Market cap9.44M

Price-Earnings ratio

-0.15

Price-Earnings ratio-0.15

Dividend yield

—

Dividend yield—

Average volume

138.37K

Average volume138.37K

High today

$0.226

High today$0.226

Low today

$0.2081

Low today$0.2081

Open price

$0.219

Open price$0.219

Volume

73.51K

Volume73.51K

52 Week high

$1.90

52 Week high$1.90

52 Week low

$0.1601

52 Week low$0.1601

Carisma Therapeutics

Why Robinhood?

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. Show more

CARM Key Statistics

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors.